Company profile: Salvia BioElectronics
1.1 - Company Overview
Company description
- Provider of neuromodulation devices for migraine, including a paper-thin implant placed under the skin near nerves associated with migraine to deliver gentle electrical pulses, the MySalvia external device to activate therapy, and the MySalvia app for monitoring and personalized treatment; also exploring bioelectronic therapy for cluster headache.
Products and services
- MySalvia app: A patient-specific application allowing patients to monitor their progress and access personalized migraine treatment aligned with their needs
- MySalvia device: An external modular device that interfaces with the implant to activate neuromodulation therapy tailored to the patient's needs for migraine management
- Paper-thin implant for migraine: A custom-engineered flexible bioelectronic foil placed under the skin near migraine-associated nerves, delivering gentle electrical pulses to calm nerves and prevent or relieve migraine symptoms
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Salvia BioElectronics
Autobahn Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage restorative treatments for neuropsychiatric and neuroimmunologic disorders, including ABX-002 (CNS-directed TRβ agonist for major depressive disorder), ABX-003 (next-generation TRβ-selective thyromimetic in IND-enabling studies), ABX-101 (S1P receptor modulator with neuroinflammatory and neuroprotective benefits), and a brain-targeting chemistry platform for tailored CNS/peripheral drug exposure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Autobahn Therapeutics company profile →
Cara Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapeutics targeting pain and inflammation, including KORSUVA (difelikefalin), an FDA-approved treatment for moderate to severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis, and research and development focused on treating pruritus in Notalgia Paresthetica.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cara Therapeutics company profile →
Prestwick Pharmaceuticals
HQ: United States
Website
- Description: Provider of therapeutic pharmaceutical drugs for chronic central nervous system diseases, offering products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea. Founded in 2002 and based in Washington, District of Columbia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prestwick Pharmaceuticals company profile →
Synaptive Medical
HQ: Canada
Website
- Description: Provider of neurosurgery, medical imaging and surgical navigation solutions, including the Synaptive Integrated Suite to integrate information and automation across interventions; Modus X robotic exoscope with 4K 3D and fluorescence visualization; Modus Plan automatic tractography segmentation; Modus Nav instrument tracking via intraoperative tractography; Synaptive MRI point-of-care MRI; ImageDrive zero-footprint HTML5 viewer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synaptive Medical company profile →
Rodin Therapeutics
HQ: United States
Website
- Description: Provider of novel therapeutics for neurological disorders by applying insights of epigenetics, leveraging key epigenetic modulators of CNS function and privileged access to Proteros’ best-in-class structural biology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rodin Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Salvia BioElectronics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Salvia BioElectronics
2.2 - Growth funds investing in similar companies to Salvia BioElectronics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Salvia BioElectronics
4.2 - Public trading comparable groups for Salvia BioElectronics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →